Word

ZEALAND PHARMA A/S

Status

Dead

Status Code

602

Status Date

Monday, October 31, 2011

Serial Number

77829889

Mark Type

4000

Filing Date

Friday, September 18, 2009

Abandoned Date

Thursday, September 22, 2011

Trademark Owner History

Zealand Pharma A-S

Classifications

1 Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; peptide substrates used in analyzing and detecting certain toxins for laboratory or research use

5 Pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, mental disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders, pregnancy and childbirth disorders, congenital anomalies, poisoning, communicable diseases, neurological diseases, psychological conditions, inflammatory diseases, reproductive diseases and sexual dysfunction; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of diseases, illnesses and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, mental disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders, pregnancy and childbirth disorders, congenital anomalies, poisoning, communicable diseases, neurological diseases, psychological conditions, inflammatory diseases, reproductive diseases and sexual dysfunction; first aid kits; diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseases, illnesses, and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, endocrine disorders, nutritional and metabolic diseases, immunity disorders, blood disorders, mental disorders, disorders of the nervous system and sensory organs, musculoskeletal system disorders, connective tissue disorders, circulatory system disorders, respiratory system disorders, digestive system and genitourinary system disorders, skin disorders, pregnancy and childbirth disorders, congenital anomalies, poisoning, communicable diseases, neurological diseases, psychological conditions, inflammatory diseases, reproductive diseases and sexual dysfunction; synthetic peptides for pharmaceutical purposes

35 Exploitation of scientific research and technology, namely, promoting collaboration and the exchange of information and resources within the scientific, research and medical communities to achieve advances in the field of health care

42 Scientific and technological services and research and design relating thereto in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; industrial analysis and research services in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; design and development of computer hardware and software; medical, biological, biotechnological, genetic, laboratory and pharmaceutical research, design and development services; design and development of computer hardware and software; medical, biological, biotechnological, genetic and pharmaceutical research, design and development services; laboratory research in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; information and consultancy services relating to all the aforesaid

44 Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services; dentistry services; medical analysis for the diagnosis and treatment of persons; pharmaceutical advice

"PHARMA A/S"

Trademark Events

Oct 31, 2011

Abandonment Notice Mailed - Failure To Respond

Oct 31, 2011

Abandonment - Failure To Respond Or Late Response

Mar 21, 2011

Notification Of Final Refusal Emailed

Mar 21, 2011

Final Refusal E-Mailed

Mar 21, 2011

Final Refusal Written

Feb 18, 2011

Teas/Email Correspondence Entered

Feb 18, 2011

Correspondence Received In Law Office

Feb 18, 2011

Teas Response To Office Action Received

Aug 19, 2010

Notification Of Non-Final Action E-Mailed

Aug 19, 2010

Non-Final Action E-Mailed

Aug 19, 2010

Non-Final Action Written

Aug 12, 2010

Previous Allowance Count Withdrawn

Jul 16, 2010

Withdrawn From Pub - Og Review Query

Jul 7, 2010

Law Office Publication Review Completed

Jul 6, 2010

Approved For Pub - Principal Register

Jun 2, 2010

Teas/Email Correspondence Entered

Jun 2, 2010

Correspondence Received In Law Office

Jun 2, 2010

Assigned To Lie

May 18, 2010

Teas Response To Office Action Received

Dec 26, 2009

Notification Of Non-Final Action E-Mailed

Dec 26, 2009

Non-Final Action E-Mailed

Dec 26, 2009

Non-Final Action Written

Dec 16, 2009

Assigned To Examiner

Sep 22, 2009

New Application Office Supplied Data Entered In Tram

Sep 22, 2009

New Application Entered In Tram